Niagen Bioscience (NASDAQ: NAGE) net income
Niagen Bioscience reported a net profit of $17.4m for fiscal 2025, 103.3% more than in fiscal 2024 ($8.6m). Its net margin was 13.4%. Earnings per share were $0.22.
Fiscal 2025 is the highest of the 10 fiscal years on record for Niagen Bioscience. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $17.4m | +103.3% | 13.4% | $0.22 |
| 2024 | $8.6m | — | 8.6% | $0.11 |
| 2023 | −$4.9m | — | −5.9% | −$0.07 |
| 2022 | −$16.5m | — | −23.0% | −$0.24 |
| 2021 | −$27.1m | — | −40.2% | −$0.40 |
| 2020 | −$19.9m | — | −33.6% | −$0.33 |
| 2019 | −$32.1m | — | −69.4% | — |
| 2018 | −$33.3m | — | −105.6% | — |
| 2017 | −$11.4m | — | −53.7% | — |
| 2016 | −$2.9m | — | −13.5% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Niagen Bioscience net income compared with its sector
By net income for its latest fiscal year, Niagen Bioscience ranks 91st of the 119 US consumer staples companies with a page on Celsmar. The sector median net margin is 3.9%; that of Niagen Bioscience, 13.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 89th | Lincoln Educational Services | $20.0m | 3.9% |
| 90th | Nature’S Sunshine Products | $19.5m | 4.1% |
| 91st | Niagen Bioscience | $17.4m | 13.4% |
| 92nd | Lifeway Foods | $13.9m | 6.5% |
| 93rd | Usana Health Sciences | $10.8m | 1.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US consumer staples stocks.
Questions about the net income of Niagen Bioscience
- How much did Niagen Bioscience earn in fiscal 2025?
- Niagen Bioscience reported a net profit of $17.4m for fiscal 2025. In fiscal 2024 it reported a net profit of $8.6m.
- What are the earnings per share of Niagen Bioscience?
- They were $0.22 in fiscal 2025, compared with $0.11 in fiscal 2024.
- What is the net margin of Niagen Bioscience?
- In fiscal 2025 its net profit was 13.4% of its revenue.
- What was the most profitable year for Niagen Bioscience?
- Of its last 10 fiscal years, fiscal 2025, with $17.4m.
- Where does Niagen Bioscience rank in its sector by net income?
- It ranks 91st of the 119 US consumer staples companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Niagen Bioscience come from?
- From the annual report (Form 10-K) that Niagen Bioscience files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Niagen Bioscience files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Niagen Bioscience: the Niagen Bioscience page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.